A protocol for fast CRISPR/Cas9-mediated gene disruption in mouse and human primary hematopoietic cells is described in this article. Cas9-sgRNA ribonucleoproteins are introduced via electroporation with sgRNAs generated through in vitro transcription and commercial Cas9. High editing efficiencies are achieved with limited time and financial cost.
from #MedicinebyAlexandrosSfakianakis via xlomafota13 on Inoreader https://ift.tt/2GOH45P
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου